Vancouver Benefits Summit

May 24, 2019
Fairmont Waterfront, Vancouver

The 2019 Vancouver Benefits Summit

The theme of this year's conference is:

Changing with the times
As today’s employees change and become more health conscious, so too must employer benefits plans. What can you do to ensure your plans are evolving with the needs of employees? Are you covering the treatments they need and offering them support to help manage their health?

At the Vancouver Benefits Summit, learn how to make your organization its healthiest by starting with your benefits plans.  

This event is designed for brokers, plan advisors and senior level personnel within plan sponsor organizations in both the public and private sectors.

Who Should Attend?

All employers responsible for benefits plans, as well as brokers and benefits consultants, are welcome to attend.

CE Credits
We will be applying to the Institute for CE credits.

Price
This full-morning conference will cost $139+tax to attend.

 

FOR SPONSORSHIP OPPORTUNITIES
FOR AGENDA
INFORMATION
FOR REGISTRATION INFORMATION

Francesca Allman
Francesca.Allman@tc.tc

Lauren Harris
Lauren.Harris@tc.tc
Emma Ramsey
Emma.Ramsey@tc.tc


Join the conversation! @BenCanMag


Twitter LinkedIn

Vancouver Benefits Summit

May 24, 2019
Fairmont Waterfront Hotel, Vancouver

**Please note that this agenda is a draft and may be subject to change



7:30 – 8:25 a.m.
Breakfast and registration



8:25 - 8:30 a.m.
Opening remarks



8:30 - 9:30 a.m.
Session one
Panel: Should there be "optional drug classes" in today’s drug plans?

Several categories of drugs are optional for a plan sponsor to include or exclude in their drug plans, such as vaccines, sexual dysfunction, fertility, smoking cessation and obesity treatments. Is it still relevant for plan sponsors to choose whether they are covered or not? Why are these categories handled differently and should they be? This session will examine whether it’s time to upgrade these categories to standard drug plan inclusions and ponder the question: Are drug plans designed in line with current therapy options and relevant conditions impacting the workplace?

Panellists:
Rob Taylor, executive vice-president, TRG, a division of HUB International
Michael Wortzman,
scientific advisor, GSK
Dr. Ali Zentner, medical director, Revolution Medical Clinic (Participation made possible by Novo Nordisk.)



9:30 - 10:00 a.m.
Session two
Cognitive Behavioural Therapy – What is it, why is it so popular, and what is with this e-therapy stuff?
Cognitive Behavioural Therapy (CBT) is the subject of many recent articles relating to benefit plan design and disability management. In addition, a variety of digital therapy products are emerging in the marketplace. The problem is that few people outside of the world of psychology and psychotherapy actually know what CBT is, let alone understand the digital versions of CBT. Learn how CBT works, how it is different than counselling, and about other evidence-based psychotherapies. This session will be of interest to anyone who is considering adding a digital product to a benefit plan, or who already has a digital product.

Speaker:
Peter Gove, innovation leader, health management, Green Shield Canada



10:00 – 10:30 a.m.
Networking break



10:30 – 11:00 a.m.
Session three
Private drug coverage, costs and cost drivers
Joe Farago will share insights into Canada’s drug coverage system with a lens on the private market. The session will provide recent comparisons on how Canada compares to the global market, a view on important new policies and provide results from new research taking a closer look at what is driving growth in Canada’s private drug plans and where it is heading. This session will provide new insight into the factors that have contributed to growth in the private drug plans and those moving forward.

Speaker:
Joe Farago, executive director, healthcare innovation, Innovative Medicines Canada



11:00 - 11:30 a.m.
Session four
Towards the tipping point: Balancing the cost of employee wellness in the era of biologics
From atopic dermatitis, to migraine prevention, to psoriatic arthritis – novel biologic-based therapies are redefining the way we manage complex conditions. They are also responsible for a rapidly growing proportion of drug reimbursement costs. With a slew of innovator molecules and biosimilars entering the Canadian market, coupled with evolving plan member expectations, plan sponsors and providers need to keep employees healthy while shifting towards a value-based reimbursement model. By mapping out the patient journey through the lens of a frontline healthcare provider, this session will explore key emerging considerations for plan sponsors investing in innovative therapies.

Speaker:
Aaron Sihota, primary care pharmacist and clinical instructor, University of British Columbia's Faculty of Pharmaceutical Sciences

(This session has been made possible by Amgen.)



11:30 a.m. - 12:00 p.m.
Session five
Facilitating drug plan savings with biosimilar medicines: Key considerations for a balanced path forward
Since the advent of the first artificially formed (recombinant) human insulin molecule in 1978, biologic medicines have continued to vastly improve treatment options for conditions such as rheumatoid arthritis, inflammatory bowel disease, and many types of cancer.  Given the complexity of their production biologic medicines come with a significant cost, accounting for 21.6 per cent of total drug spend in Canada in 2017.  Biosimilar medicines are biologics that are highly similar to their Health Canada approved reference biologic but are not the same as generic drugs. Given the potential for significant cost savings from increased biosimilars uptake, this session will focus on key considerations across a variety of therapeutic areas, including patient perspectives and available clinical evidence. Recommendations to facilitate long-term cost savings in the biologic treatment space will also be discussed.        
  
Speaker:
Ganive Bhinder, board member, Canadian Society of Intestinal Research

(This session has been made possible by Sanofi.)



12:00 -12:05 p.m.
Closing remarks

Vancouver Benefits Summit

Vancouver Benefits Summit - Speakers CONFERENCE SPEAKERS



 

Ganive Bhinder

Ganive Bhinder

Ganive Bhinder is a patient advocate and health researcher with extensive experience in patient outreach, knowledge translation and mobilizing evidence to impact policy. She has a doctorate in experimental medicine from the University of British Columbia (UBC) and has co-authored over 15 peer-reviewed scientific manuscripts. She has received several awards from the Canadian Institutes of Health Research, UBC and BC Children’s Hospital Research Institute. Bhinder is passionate about building bridges between patients, non-profit organizations, policy makers, healthcare providers, clinical and academic researchers and industry to positively impact the public healthcare landscape. Through her work as executive director of the Better Pharmacare Coalition and on the boards of the Canadian Society of Intestinal Research and Best Medicines Coalition, Bhinder strives to ensure that health policies and funding decisions are patient-centered and evidence-based. 




Joe Farago

Joe Farago

Joe Farago is the executive director of private payers and investment at Innovative Medicines Canada. He joined the organization in January 2016, and in this role, he is responsible for the private payer market and the national innovation strategy. Farago is leading the pharmaceutical sector's efforts in taking a more proactive, research-based approach to addressing today’s issues, ensuring tomorrow’s workforces in Canada have strong private market coverage that is best suited to meeting their needs. Ensuring employees are healthy and productive at work is a fundamental value of healthy private drug benefits. Over the last 27 years, Farago has acquired a vast knowledge of the Canadian pharmaceutical and specialty biopharmaceutical markets. He has a wide range of experience in market access, government affairs, sales, marketing and operations. Farago has had the opportunity to be part of establishing two organizations in the Canadian market from the ground up and brings a strong understanding of market access success and organizational development. He started his pharmaceutical career with Servier Canada in 1989, and then he entered the plasma protein specialty market with CSL Limited in 2007, where he was instrumental in establishing and building the Canadian organization to a market leader. Farago attended Carleton University, graduating with a bachelor of science degree, and he currently lives in Manotick, Ontario, with his wife and their three children.


 

Peter Gove

Peter Gove

Peter Gove, innovation leader, health management with Green Shield Canada (GSC), has oversight for initiatives under GSC’s Change4Life banner. Prior to coming to GSC, Gove was responsible for the national disability management and life insurance claims program for a large Canadian life insurance company. Gove has a master’s degree in social work and is a registered social worker. Continuing his education, he started a doctorate program in applied health science at the University of Waterloo. He has presented internationally in the areas of health management and disability management and was the recipient of the 2014 vision and values award, presented by the Canadian Life and Health Insurance Association.


 

Aaron Sihota

Aaron Sihota

Aaron Sihota is a primary care pharmacist and clinical instructor at the University of British Columbia’s (UBC) faculty of pharmaceutical sciences. As part of a specialized collaborative pharmacy that focuses in outcome-based immunotherapy and dermatology services, Sihota has worked in collaboration with a group of specialist physicians and nurses to educate, monitor, and optimize patient medication therapy leveraging emerging digital health technology. Sihota is the co-creator of an advanced dermatology elective course at the UBC’s faculty of pharmaceutical sciences for entry to practice doctor of pharmacy students. The first offering of its kind in North America explores dermatological conditions from the unique lens of collaborative practice; faculty include dermatologists as well as rheumatologists and dermatology residents. Sihota is the chapter author for the management of acne and atopic dermatitis in the Compendium of Therapeutics for Minor Ailments (CTMA) and is a regular skincare columnist for Pharmacy Practice + Business magazine. He has a keen interest in fostering collaborative care opportunities between primary care practitioners, dermatologists and rheumatologists and has been involved with educating dermatology residents. Sihota has developed multiple accredited dermatology and rheumatology healthcare education programs as well as biologics resources and tools, and is regularly called on to participate at forums across North America to explore trends and innovation in specialty care delivery.

 


 

Rob Taylor

Rob Taylor

Rob Taylor is the executive vice-president of TRG, which is a division of HUB International. He is currently assisting HUB’s build of their national benefits strategy and brand focusing on how to move the needle in areas of pharmacy, health and digital. He has been helping clients articulate and construct their ideal future for 30 years. He knows that a carefully crafted benefits solution can be more than just sustainable—it can reflect a corporate vision, strengthen the critical connection between employer and employee, and help that relationship reach its full potential. Taylor uses his experience and insights to ensure plan sponsors are ideally positioned to make a real impact, as well as a real profit. He is a certified financial planner, a chartered life underwriter, a chartered financial consultant and a certified employee benefit specialist. He is a member of the Conference for Advanced Life Underwriting; the Canadian Pension and Benefits Institute; and Advocis, Canada’s largest association of professional advisors. He’s also the author of numerous editorial articles, blogs and his first book, The Future of You. He currently is working with other financial services industry leaders to elevate the voice of the plan sponsor and members through the creation of an organization specific for group benefits. 

 


 

Michael Wortzman

Michael Wortzman

Michael Wortzman is a scientific advisor in GSK’s medical division, with an expertise in vaccines and a passion for clear communication of science. Prior to joining GSK, Wortzman served as the assistant director of research at the Canadian Cancer Society Research Institute, where he oversaw the scientific peer review process for a $40 million annual investment. He also served on the board of the Canadian Cancer Research Alliance, aimed to shape the national cancer research strategy for the ultimate benefit of patients. Wortzman received his doctorate in immunology from the University of Toronto, where he studied the immune response to acute and chronic viral infections.

 


 

Dr. Ali Zentner

Dr. Ali Zenter

Dr. Ali Zentner received her undergraduate medical degree from McMaster University and completed her internal medicine residency with an extra year of cardiology training at the University of Calgary.  She is a diplomate of the American Board of Obesity Medicine. Dr. Zentner was the medical director of the Live Well Exercise Clinics from 2013-2018. Live Well is a unique prevention clinic which offers medically supervised exercise based programs in the lower mainland and expanding across the country. As medical director Dr. Zentner was instrumental in establishing these programs and bringing them to the mainstream. From 2015-2018, Dr. Zentner was the medical director of the Vancouver Island Bariatric Program and built the program into a multidisciplinary bariatric program which now supervises the bariatric surgeries of over 200 patients annually. After three years as director, she moved on to establish a similar bariatric program within Fraser Health region. With a wealth of clinical and practical experience, Dr. Zentner built Revolution Medical Clinic and serves as its medical director. Revolution is the realization of almost two decades in practice in obesity and metabolic medicine.



 

More speakers to be posted shortly.

Event Location: Fairmont Waterfront, Vancouver

Contemporary accommodations bring more fun to travelers staying at 489-room The Fairmont Waterfront, a luxury hotel set in a prime location in Vancouver where lots of fun destinations are within reach. A wide array of delicious food choices are featured at ARC Restaurant + Bar, with guests and locals invited to indulge in the local and handcrafted cuisine offered throughout the day


Address:

900 Canada Place Way, Vancouver, BC V6C3L5

For more information about event logistics, please contact Emma Ramsey at
Emma.Ramsey@tc.tc


 



FOR SPONSORSHIP OPPORTUNITIES
FOR AGENDA
INFORMATION
FOR REGISTRATION INFORMATION

Francesca Allman
Francesca.Allman@tc.tc

Lauren Harris
Lauren.Harris@tc.tc
Emma Ramsey
Emma.Ramsey@tc.tc

Join the conversation! @BenCanMag


Twitter